Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c
Enhancing Cardiovascular Health Equity in Mothers and Children Through Home Visiting
1 other identifier
observational
18
1 country
1
Brief Summary
Conduct a pilot study to test feasibility of doing remote data collection with a point of care device that measures HbA1c.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2023
CompletedFirst Posted
Study publicly available on registry
February 13, 2023
CompletedStudy Start
First participant enrolled
February 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2024
CompletedResults Posted
Study results publicly available
July 15, 2025
CompletedJuly 15, 2025
July 1, 2025
1.2 years
February 1, 2023
April 23, 2025
July 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility to Obtain HbA1c Through Remote Data Collection
Feasibility will be measured by how many participants are able to obtain HbA1c measure through remote data collection and participant's satisfaction with this means of data collection.
Baseline
Interventions
After consent the participant will meet with the research team virtually to obtain HbA1c. The HbA1c self check equipment will be sent to the participant. During the video call the research team will talk the participant through obtaining their HbA1c with the point of care device.
Eligibility Criteria
Pregnant or postpartum women who are currently or have recently participated in the Parents as Teachers home visiting program.
You may qualify if:
- English speaking
- Screened or participating in NCT04253977
- Able to give informed consent for participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University in St. Louis
St Louis, Missouri, 63130, United States
Results Point of Contact
- Title
- Cindy Schwarz
- Organization
- Washington University in St. Louis
Study Officials
- PRINCIPAL INVESTIGATOR
Debra Haire-Joshu, PhD
Washington University School of Medicine
- PRINCIPAL INVESTIGATOR
Victor G Davila-Roman, MD,FACC,FASE
Washington University School of Medicine
- PRINCIPAL INVESTIGATOR
Rachel G Tabak, PhD, RD
Washington University School of Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2023
First Posted
February 13, 2023
Study Start
February 24, 2023
Primary Completion
April 25, 2024
Study Completion
April 25, 2024
Last Updated
July 15, 2025
Results First Posted
July 15, 2025
Record last verified: 2025-07